TATYY
TATE & LYLE PLC SPONS ADR
$30.20
-0.98%
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$19.0K
Inst. Activity0 buys / 1 sells
Prev Close $30.50
Recent Activity
Inst.
RHUMBLINE ADVISERS — TRIM
975 shares ($28.3K)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$31.70
Current $30.20
Low $31.70
Median $31.70
High $31.70
1 analysts
$31.70
$31.70
Analyst Ratings
2Strong Buy
5Buy
6Hold
1Sell
0Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $1.97 ▼ -13.5% | $1.97 — $1.97 | -9% YoY | 1 |
| Next FY | $2.53 ▼ -0.6% | $2.53 — $2.53 | 29% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RHUMBLINE ADVISERS | $19.0K | TRIM |
1 institutional holders with $19.0K total value (975 shares) as of 2026-Q1. Top holders: RHUMBLINE.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RHUMBLINE ADVISERS | 975 | $19.0K | 100.0% | TRIM -30.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | TRIM | 1,395 | 975 | -30.1% | $28.3K | 2025-Q2 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 50% buy across 14 analysts — 2 strong buy, 5 buy, 6 hold, 1 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$31.70 mean target
$31.70 Low
$31.70 High
| Metric | Value |
|---|---|
| Current Price | $30.20 |
| Target Low | $31.70 |
| Target Mean | $31.70 |
| Target Median | $31.70 |
| Target High | $31.70 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2027-03-31 |
$1.97 | $1.97 | $1.97 | -9.4% | -13.5% | 0↑ 1↓ | $2.0B | 0.6% | 1 |
| Next FY 2028-03-31 |
$2.53 | $2.53 | $2.53 | 28.6% | -0.6% | 1↑ 0↓ | $2.1B | 3.1% | 1 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 5 | 6 | 1 | 0 | 50% | |
| May 1, 2026 | 5 | 5 | 6 | 1 | 0 | 59% | |
| Apr 1, 2026 | 5 | 5 | 6 | 1 | 0 | 59% | |
| Mar 1, 2026 | 5 | 5 | 6 | 1 | 0 | 59% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.